Grant opportunity preview
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Offered by National Institutes of Health
HealthcareNationalNovember 16, 2027
Opportunity summary
This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for "high priority" genetic c…
Sign in to review full eligibility requirements, application details, matching insights, and verified source links.